Vitamin e in Atopic Dermatitis: From Preclinical to Clinical Studies

17Citations
Citations of this article
72Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background: Oxidative stress and inflammation are some of the proposed mechanisms involved in the pathogenesis of atopic dermatitis (AD). Current pharmacotherapeutic approaches are effective yet they are not without adverse effects. Vitamin E has great potential as an adjunctive treatment for AD owing to its antioxidant and anti-inflammatory bioactivities. Summary: This review article summarizes the current available evidence from cellular, animal and clinical studies on the relationship between vitamin E and AD. The future prospects of vitamin E are also discussed. Vitamin E in practice does not show any toxicity to humans within a range of reasonable dosage. Albeit rarely, vitamin E as a contact allergen should be considered. Collectively, this review envisaged vitamin E as an adjunctive treatment for AD patients. Future research on the distinct effects of different vitamin E isoforms as well as their delivery system in skin disorders is needed.

Cite

CITATION STYLE

APA

Teo, C. W. L., Tay, S. H. Y., Tey, H. L., Ung, Y. W., & Yap, W. N. (2021, June 1). Vitamin e in Atopic Dermatitis: From Preclinical to Clinical Studies. Dermatology. S. Karger AG. https://doi.org/10.1159/000510653

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free